Independent Medical Education

GSK calls for applicants for Independent Medical Education Fund

Novel approach to funding is part of GSK’s changes in how it works with and supports healthcare professionals

GSK Ireland is calling for interested applicants to apply for its grant scheme designed to support medical education in Ireland. Now in its third year, the programme has already provided over €140,000 in funding since launch. This independent approach to supporting medical education is part of widespread changes GSK has introduced around fundamentally transforming all of its interactions and relationships with healthcare professionals. This allows GSK to continue to support medical education in Ireland but in a way that removes any perception of influence or commercial bias: any training given will be provided at arm’s length and without GSK’s input into either its content or delivery.

Previous recipients include AIDS West, UCC, Asthma Society of Ireland and Galway University Hospital.

Commenting on the applications launch, Martijn Akveld, Director of Medical Affairs GSK Ireland said:

This fund allows GSK to continue its strong commitment to medical education and support educational programmes that make a real difference to Irish patients’ lives in a totally transparent manner independent from GSK. It’s been really encouraging to see the impact our support has made to a variety of institutions since we began and the feedback from all recipients around the programme has been overwhelmingly positive

Applications are invited from healthcare service providers, professional medical societies, patient groups or academic institutions that train healthcare professionals.

What is different about this programme is GSK has no involvement or control over any aspect of the content, faculty or implementation of the programme such as the logistics or participant selection.

Criteria for selection include:

Outcome driven: We want to support education initiatives with clear, measurable outcomes so that the benefit to patients is measurable and demonstrable.

Patient Focused: We also want to concentrate on disease areas in which there is a genuine patient need and in which we have a mutual scientific interest.

Arms-length: We have no involvement or influence on the education development, logistics or participant selection.

Need: We focus our financial resource on programmes that have the greatest potential to enable people to do more, feel better and live longer.